Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Am J Kidney Dis
2008 Dec 01;526:1096-103. doi: 10.1053/j.ajkd.2008.07.041.
Show Gene links
Show Anatomy links
Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis.
Monico CG, Weinstein A, Jiang Z, Rohlinger AL, Cogal AG, Bjornson BB, Olson JB, Bergstralh EJ, Milliner DS, Aronson PS.
???displayArticle.abstract???
BACKGROUND: Urinary oxalate is a major risk factor for calcium oxalate stones. Marked hyperoxaluria arises from mutations in 2 separate loci, AGXT and GRHPR, the causes of primary hyperoxaluria (PH) types 1 (PH1) and 2 (PH2), respectively. Studies of null Slc26a6(-/-) mice have shown a phenotype of hyperoxaluria, hyperoxalemia, and calcium oxalate urolithiasis, leading to the hypothesis that SLC26A6 mutations may cause or modify hyperoxaluria in humans.
STUDY DESIGN: Cross-sectional case-control.
SETTING & PARTICIPANTS: Cases were recruited from the International Primary Hyperoxaluria Registry. Control DNA samples were from a pool of adult subjects who identified themselves as being in good health.
PREDICTOR: PH1, PH2, and non-PH1/PH2 genotypes in cases.
OUTCOMES & MEASURES: Homozygosity or compound heterozygosity for SLC26A6 variants. Functional expression of oxalate transport in Xenopus laevis oocytes.
RESULTS: 80 PH1, 6 PH2, 8 non-PH1/PH2, and 96 control samples were available for SLC26A6 screening. A rare variant, c.487C-->T (p.Pro163Ser), was detected solely in 1 non-PH1/PH2 pedigree, but this variant failed to segregate with hyperoxaluria, and functional studies of oxalate transport in Xenopus oocytes showed no transport defect. No other rare variant was identified specifically in non-PH1/PH2. Six additional missense variants were detected in controls and cases. Of these, c.616G-->A (p.Val206Met) was most common (11%) and showed a 30% reduction in oxalate transport. To test p.Val206Met as a potential modifier of hyperoxaluria, we extended screening to PH1 and PH2. Heterozygosity for this variant did not affect plasma or urine oxalate levels in this population.
LIMITATIONS: We did not have a sufficient number of cases to determine whether homozygosity for p.Val206Met might significantly affect urine oxalate.
CONCLUSIONS: SLC26A6 was effectively ruled out as the disease gene in this non-PH1/PH2 cohort. Taken together, our studies are the first to identify and characterize SLC26A6 variants in patients with hyperoxaluria. Phenotypic and functional analysis excluded a significant effect of identified variants on oxalate excretion.
Chernova,
Functional comparison of mouse slc26a6 anion exchanger with human SLC26A6 polypeptide variants: differences in anion selectivity, regulation, and electrogenicity.
2005, Pubmed,
Xenbase
Chernova,
Functional comparison of mouse slc26a6 anion exchanger with human SLC26A6 polypeptide variants: differences in anion selectivity, regulation, and electrogenicity.
2005,
Pubmed
,
Xenbase Clark,
Species differences in Cl- affinity and in electrogenicity of SLC26A6-mediated oxalate/Cl- exchange correlate with the distinct human and mouse susceptibilities to nephrolithiasis.
2008,
Pubmed
,
Xenbase Curhan,
24-h uric acid excretion and the risk of kidney stones.
2008,
Pubmed Freel,
Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice.
2006,
Pubmed Goldfarb,
A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry.
2005,
Pubmed Haleblian,
Nephrolithiasis in identical twins: the impact of nature vs nurture.
2007,
Pubmed Hassan,
Regulation of anion exchanger Slc26a6 by protein kinase C.
2007,
Pubmed
,
Xenbase HERRING,
Observations on the analysis of ten thousand urinary calculi.
1962,
Pubmed Hiatt,
The frequency of kidney and urinary tract diseases in a defined population.
1982,
Pubmed Jiang,
Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6.
2006,
Pubmed Jiang,
Specificity of anion exchange mediated by mouse Slc26a6.
2002,
Pubmed
,
Xenbase Johnson,
Renal stone epidemiology: a 25-year study in Rochester, Minnesota.
1979,
Pubmed Karniski,
Immunolocalization of sat-1 sulfate/oxalate/bicarbonate anion exchanger in the rat kidney.
1998,
Pubmed Knauf,
Identification of a chloride-formate exchanger expressed on the brush border membrane of renal proximal tubule cells.
2001,
Pubmed
,
Xenbase Kocinsky,
NHE3 phosphorylation at serines 552 and 605 does not directly affect NHE3 activity.
2007,
Pubmed Lohi,
Mapping of five new putative anion transporter genes in human and characterization of SLC26A6, a candidate gene for pancreatic anion exchanger.
2000,
Pubmed Lohi,
Isoforms of SLC26A6 mediate anion transport and have functional PDZ interaction domains.
2003,
Pubmed
,
Xenbase Monga,
Renal stone risk in a simulated microgravity environment: impact of treadmill exercise with lower body negative pressure.
2006,
Pubmed Monga,
Genetic heritability of urinary stone risk in identical twins.
2006,
Pubmed Monico,
Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II.
2002,
Pubmed Robertson,
Importance of mild hyperoxaluria in the pathogenesis of urolithiasis--new evidence from studies in the Arabian peninsula.
1993,
Pubmed Robertson,
Risk factors in calcium stone disease of the urinary tract.
1978,
Pubmed Robertson,
The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?
1980,
Pubmed Rumsby,
Oxalate transport as contributor to primary hyperoxaluria: the jury is still out.
2008,
Pubmed Soucie,
Demographic and geographic variability of kidney stones in the United States.
1994,
Pubmed Trudeau,
HERG, a human inward rectifier in the voltage-gated potassium channel family.
1995,
Pubmed Van Acker,
Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: a novel type of primary hyperoxaluria.
1996,
Pubmed Waldegger,
Cloning and characterization of SLC26A6, a novel member of the solute carrier 26 gene family.
2001,
Pubmed
,
Xenbase Wang,
Identification of an apical Cl(-)/HCO3(-) exchanger in the small intestine.
2002,
Pubmed
,
Xenbase Wilson,
Modified enzyme-based colorimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference: reference values and sample handling procedures.
1991,
Pubmed Xie,
Molecular characterization of the murine Slc26a6 anion exchanger: functional comparison with Slc26a1.
2002,
Pubmed
,
Xenbase
